Aug 07, 2024 / 08:30PM GMT
Operator
Good afternoon, and welcome to deliver Relmada Therapeutics Inc.'s second-quarter 2024 earnings conference call. (Operator Instructions) This call is being recorded on Wednesday, August 7, 2024.
I would now like to turn the conference over to Tim McCarthy, LifeSci Advisors. Please go ahead, sir.
Tim McCarthy - Relmada Therapeutics Inc - Investor Relations
Thank you, operator, and thank you all for joining us this afternoon. With me on today's call are Dr. Sergio Traversa, Chief Executive Officer; and Maged Shenouda, Chief Financial Officer. Definitely in Relmada issued a press release providing a business update and announcing financial results for the quarter ended June 30, 2024. Please note that certain information discussed on the call today is covered under the Safe Harbors provision of the Private Securities Litigation Reform Act.
We caution listeners that during this call, Relmada as management team will be making forward-looking statements. Actual results could differ materially from those stated or implied by these forward-looking
Q2 2024 Relmada Therapeutics Inc Earnings Call Transcript
Aug 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers